Cancer immunology and immunotherapy

Open Access
Impact of immunosuppressants on tumor pulmonary metastasis: new insight into transplantation for hepatocellular carcinoma
Jinyan Chen, Huigang Li, Jianyong Zhuo, Zuyuan Lin, Zhihang Hu, Chiyu He, Xiang Wu, Yiru Jin, Zhanyi Lin, Renyi Su, Yiyang Sun, Rongsen Wang, Jiancai Sun, Xuyong Wei, Shusen Zheng, Di Lu and Xiao Xu

Cancer Biology & Medicine November 2024, 21 (11) 1033-1049; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0267
Open Access
Potential treatment approaches for malignant peritoneal mesothelioma: in vivo and in vitro experimental study of natural killer cell immunotherapy
Heliang Wu, Yi Wang, Yulin Lin, Ru Ma, Xuemei Du, Yandong Su, Rui Yang, Zhiran Yang, Xinli Liang, Yinguang Zhang, Xiaoqing Liang, Zhonghe Ji, Chunning Lai, Yajing Huang and Yan Li

Cancer Biology & Medicine November 2024, 21 (11) 1078-1094; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0218
Open Access
PD-1 and LAG-3 dual blockade: emerging mechanisms and potential therapeutic prospects in cancer
Xiangyu Qiu, Zhaoan Yu, Xiaoqing Lu, Xin Jin, Jinrong Zhu and Rongxin Zhang

Cancer Biology & Medicine November 2024, 21 (11) 970-976; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0436
Open Access
Complex role of neutrophils in the tumor microenvironment: an avenue for novel immunotherapies
Mao Zhang, Haokai Qin, Yingcheng Wu and Qiang Gao

Cancer Biology & Medicine October 2024, 21 (10) 849-863; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0192
Open Access
Enhancement of anti-PD-L1 antibody plus anlotinib efficacy due to downregulation of PD-L1 in the micro-conduit endothelium within the tumor: a randomized double-blind trial
Cuicui Zhang, Tianqing Chu, Qiming Wang, Ying Cheng, Yongxiang Zhang, Ruili Wang, Leilei Ma, Chaonan Qian, Baohui Han and Kai Li

Cancer Biology & Medicine October 2024, 21 (10) 951-962; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0423
Open Access
Impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of immunotherapy in patients with chronic hepatitis B-related hepatocellular carcinoma
Jiaxin Han, Wentao Kuai, Liu Yang, Xuemei Tao, Yuekui Wang, Minghui Zeng, Yuqin Li, Yuqiang Mi, Ningning Zhang, Wei Lu and Liang Xu

Cancer Biology & Medicine September 2024, 21 (9) 813-825; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0048
Open Access
Modeling human gastric cancers in immunocompetent mice
Weihong Zhang, Shilong Wang, Hui Zhang, Yan Meng, Shi Jiao, Liwei An and Zhaocai Zhou

Cancer Biology & Medicine July 2024, 21 (7) 553-570; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0124
Open Access
Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei
Qidi Zhao, Tian Wei, Ru Ma, Yubin Fu, Rui Yang, Yandong Su, Yang Yu, Bing Li and Yan Li

Cancer Biology & Medicine July 2024, 21 (7) 586-605; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0109
Open Access
Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer
Ming Bai, Yao Lu, Chunmei Shi, Jianwei Yang, Wei Li, Xianli Yin, Chenghui Huang, Lin Shen, Liangzhi Xie and Yi Ba

Cancer Biology & Medicine July 2024, 21 (7) 636-650; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0301
Open Access
Immune checkpoint inhibitors: breakthroughs in cancer treatment
Xueqing Kong, Jinyi Zhang, Shuwei Chen, Xianyang Wang, Qing Xi, Han Shen and Rongxin Zhang

Cancer Biology & Medicine June 2024, 21 (6) 451-472; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0055

Main menu

User menu

Search

Cancer immunology and immunotherapy

Pages

Navigate

More Information

For Authors

Journal Services